Risultati della ricerca - Patrick Maison

  • Mostra 1 - 17 risultati su 17
Raffina i risultati
  1. 1
    Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts

    Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts di Patrick Maison, Patrick Maison, Mahmoud Zureik, Virginie Hivert, Jesper Kjaer, Roman Hossein Khonsari, Gianluca Trifirõ, Christelle Ratignier-Carbonneil

    Pubblicazione 2022-07-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities

    Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities di Wahiba Oualikene-Gonin, Marie-Christine Jaulent, Jean-Pierre Thierry, Sofia Oliveira-Martins, Sofia Oliveira-Martins, Laetitia Belgodère, Patrick Maison, Patrick Maison, Patrick Maison, Joël Ankri, The Scientific Advisory Board of ANSM

    Pubblicazione 2024-08-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  3. 3
    The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study

    The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study di Amine Benhabib, Saïd Ioughlissen, Christelle Ratignier-Carbonneil, Patrick Maison

    Pubblicazione 2020-03-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysis

    Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysis di Priscilla Ajiji, Anil Uzunali, Emmanuelle Ripoche, Emilie Vittaz, Thierry Vial, Patrick Maison

    Pubblicazione 2021-07-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience

    Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience di Laëtitia Belgodère, Joseph Emmerich, Joseph Emmerich, Nicolas Albin, Nicolas Albin, Trystan Bacon, Trystan Bacon, Trystan Bacon, Trystan Bacon, Pascale Daynes, Pascale Daynes, Stéphane Vignot, Stéphane Vignot, Thierry Vial, Thierry Vial, Guillaume Renaud, Carole Le Saulnier, Corine Maillard-Couvreur, Mélanie Cachet, Marie-Laure Veyries, Rym Youdarene, Wahiba Oualikene-Gonin, Christelle Ratignier-Carbonneil, Patrick Maison, Patrick Maison, Patrick Maison

    Pubblicazione 2023-11-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

    Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A... di Stéphane Vignot, Stéphane Vignot, Pascale Daynes, Pascale Daynes, Trystan Bacon, Trystan Bacon, Thierry Vial, Thierry Vial, Olivier Montagne, Olivier Montagne, Nicolas Albin, Nicolas Albin, Joseph Emmerich, Joseph Emmerich, Christelle Ratignier-Carbonneil, Dominique Martin, Patrick Maison, Patrick Maison

    Pubblicazione 2021-04-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products

    Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines... di Wahiba Oualikene-Gonin, Valérie Sautou, Eric Ezan, Henri Bastos, Eric Bellissant, Laëtitia Belgodère, Patrick Maison, Patrick Maison, Patrick Maison, Joël Ankri, The Scientific Advisory Board of the ANSM, Joël Ankri, Janine Barbot, Robert Barouki, Henri Bastos, Éric Bellissant, Christiane Druml, Éric Ezan, Didier Houssin, Walter Janssens, Marie-Christine Jaulent, Maria Emilia Monteiro, Dominique Pougheon, Vololona Rabeharisoa, Victoria Rollason, Valérie Sautou, Jean-Paul Vernant

    Pubblicazione 2023-03-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet

    Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet di Christine Azar, Delphine Allué, Marie B. Valnet-Rabier, Laurent Chouchana, Fanny Rocher, Dorothée Durand, Nathalie Grené-Lerouge, Nadine Saleh, Patrick Maison

    Pubblicazione 2021-06-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Neuroendocrine disturbances in Huntington's disease.

    Neuroendocrine disturbances in Huntington's disease. di Nadine Saleh, Stéphane Moutereau, Alexandra Durr, Pierre Krystkowiak, Jean-Philippe Azulay, Christine Tranchant, Emmanuel Broussolle, Françoise Morin, Anne-Catherine Bachoud-Lévi, Patrick Maison

    Pubblicazione 2009-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority

    Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority di Stéphane Vignot, Alban Dhanani, Isabelle Sainte-Marie, Laure de Ligniville Lajavardi, Gwennaelle Even, Muriel Echemann, Nina Hulin, Claire Ménoret, Patrick Maison, Christelle Ratignier-Carbonneil

    Pubblicazione 2022-08-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Glanuloplasty with Oral Mucosa Graft following Total Glans Penis Amputation

    Glanuloplasty with Oral Mucosa Graft following Total Glans Penis Amputation di Kwaku Appiah, George Amoah, Roland Azorliade, Kofi Gyasi-Sarpong, Ken Aboah, Douglas Arthur, Baah Nyamekye, Kwaku Otu-Boateng, Patrick Maison, Benjamin Twumasi-Frimpong, Issac Opoku Antwi, Edwin Yenli

    Pubblicazione 2014-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.

    Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting. di Laurent Cleret de Langavant, Sophie Sudraud, Christophe Verny, Pierre Krystkowiak, Clémence Simonin, Philippe Damier, Jean-François Demonet, Frédéric Supiot, Amandine Rialland, David Schmitz, Patrick Maison, Katia Youssov, Anne-Catherine Bachoud-Lévi

    Pubblicazione 2015-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease.

    Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease. di Linda Salem, Nadine Saleh, Gaelle Désaméricq, Katia Youssov, Guillaume Dolbeau, Laurent Cleret, Marie-Laure Bourhis, Jean-Philippe Azulay, Pierre Krystkowiak, Christophe Verny, Françoise Morin, Stéphane Moutereau, French Huntington Study Group, Anne-Catherine Bachoud-Lévi, Patrick Maison

    Pubblicazione 2016-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort.

    Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort. di Gaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, Perrine Charles, Alexandra Durr, Katia Youssov, Clémence Simonin, Jean-Philippe Azulay, Christine Tranchant, Cyril Goizet, Philippe Damier, Emmanuel Broussolle, Jean-François Demonet, Graca Morgado, Laurent Cleret de Langavant, Isabelle Macquin-Mavier, Anne-Catherine Bachoud-Lévi, Patrick Maison

    Pubblicazione 2014-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  15. 15
    A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease

    A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease di Claire-Marie Dhaenens, Sylvie Burnouf, Clémence Simonin, Edwige Van Brussel, Alain Duhamel, Luc Defebvre, Cécile Duru, Isabelle Vuillaume, Cécile Cazeneuve, Perrine Charles, Patrick Maison, Sabrina Debruxelles, Christophe Verny, Hélène Gervais, Jean-Philippe Azulay, Christine Tranchant, Anne-Catherine Bachoud-Levi, Alexandra Dürr, Luc Buée, Pierre Krystkowiak, Bernard Sablonnière, David Blum

    Pubblicazione 2009-09-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)

    Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for M... di Robert Barouki, Joël Ankri, Patrick Maison, Christiane Druml, Valérie Sautou, Eric Bellissant, Laëtitia Belgodère, Dominique Pougheon Bertrand, Marie Christine Jaulent, Vololona Rabeharisoa, Walter Janssens, Victoria Rollason, Janine Barbot, Jean Paul Vernant, Wahiba Oualikene Gonin, Henri Bastos, Éric Ezan, Didier Houssin, Maria Emilia Monteiro, Dominique Pougheon Bertrand, Marie-Christine Jaulent, Jean-Paul Vernant

    Pubblicazione 2023-05-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  17. 17
    COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

    COMT Val158Met Polymorphism Modulates Huntington's Disease Progression. di Ruth de Diego-Balaguer, Catherine Schramm, Isabelle Rebeix, Emmanuel Dupoux, Alexandra Durr, Alexis Brice, Perrine Charles, Laurent Cleret de Langavant, Katia Youssov, Christophe Verny, Vincent Damotte, Jean-Philippe Azulay, Cyril Goizet, Clémence Simonin, Christine Tranchant, Patrick Maison, Amandine Rialland, David Schmitz, Charlotte Jacquemot, Bertrand Fontaine, Anne-Catherine Bachoud-Lévi, French Speaking Huntington Group

    Pubblicazione 2016-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: